Trump Picks Former Pharma Exec, Ex-Bush Official to Lead Department of Health and Human Services

Senate Minority Leader Chuck Schumer suggested the confirmation proceedings for Azar will be tough. Deputy Secretary of Health and Human Services, Alex Azar is seen meeting with a French researcher in Paris on Feb. Bush. “This confirmation hearing process will be a referendum on the Trump administration’s repeated efforts to sabotage our health care system and raise premiums on millions of Americans,” the New York Democrat said in a statement. In an October letter, Reps. House Speaker Paul Ryan, however, called Azar “an experienced and highly capable leader who knows what it takes to tackle big challenges in health care.” He said he expects Azar to be confirmed through the Senate “swiftly.”
Following Yale Law School, Azar clerked for Supreme Court Justice Antonin Scalia, and later joined the Whitewater independent counsel headed by his “mentor” Ken Starr. Trump campaigned on lowering drug prices, but has yet to take any real action on the issue. As part of his role at Lilly USA, Azar was on the board of directors for the Boards of the Biotechnology Industry Organization (BIO), a drug lobbyinggroup. In tweeting the announcement, Trump called Azar a “star for better healthcare and lower drug prices.”
He previously served as HHS general counsel and deputy secretary for President George W. (Credit: STEPHANE DE SAKUTIN/AFP/Getty Images)
During Azar’s tenure leading Lilly, the company was accused of routinely increasing drug prices. and became president of Lilly USA in 2012. Following his time with the administration, he worked for pharmaceutical giant Eli Lilly & Co. 6, 2017. The administration has been working on an executive order but it has yet to be released. Bush administration official, to succeed Tom Price as the secretary of the Department of Health and Human Services. President Donald Trump on Monday announced he is nominating Alex Azar, a former pharmaceutical company executive and George W. Price resigned in September in the midst of a scandal over his use of private planes during his time as secretary. 38.907192
-77.036871 He left Lilly USA and BIO in January. While acting as the U.S. Raul Grijalva, D-Arizona, Mark Pocan, D-Wisconsin, and Jan Schakowsky, D-Illinois, wrote that under his leadership, Azar’s company fought “against federal and state legislation to increase drug pricing transparency.” And a lawsuit filed in Massachusetts in early 2017 alleges that the company shot up prices on insulin “in near lock step” with two other pharmaceutical manufacturers, according to The New York Times. He also worked on Bush’s 2000 presidential campaign before his first stint at HHS. A representative for Eli Lilly told CNN in a statement that the company “makes all of its pricing decisions independently and in strict compliance with all laws, regulations and guidelines applicable to our business.”
“We are committed to providing the best medicines to people at the best price available,” the statement continued.